The FAME 3 Trial: Quality of Life After Fractional Flow Reserve-guided Stenting Compared With Coronary Bypass Surgery
Reported from ACC 2022
Luis Ortega-Paz interviews Frederik Zimmermann, first co-author of the FAME 3 Trial which he presented during the American College of Cardiology’s annual scientific sessions. The trial was published simultaneously in the journal Circulation.
The conclusion was that PCI guided by FFR leads to a faster improvement in quality of life, with similar outcomes at 12-month follow-up compared with CABG surgery.
No comments yet!